FDA Warns Of False Negative COVID Tests From Virus Mutations
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The FDA has alerted health care providers and labs that genetic variants of the novel coronavirus including an emerging variant first detected in the United Kingdom called B.1.1.7 could lead to false negative Covid-19 test results.

The FDA noted that false negative results can occur with any molecular test for the detection of the virus if a mutation has occurred in the part of the virus's genome that the test examines. The risk that these mutations will impact overall testing accuracy is low. If Covid-19 is suspected after a negative test, the agency recommends repeat testing with a different test.

The agency notes three Covid-19 tests authorized in the United States may be impacted by genetic variants MesaBiotech Accula, TaqPath Covid-19 Combo Kit and Linea Covid-19 Assay Kit but the impact does not appear to be significant.

Since the TaqPath and Linea Covid-19 tests detect multiple genetic targets, the overall test sensitivity should not be impacted, the FDA noted. However, if certain patterns emerge in individual results from those tests, labs might consider further genetic sequencing of specimens.

"The FDA will continue to monitor SARS-CoV-2 genetic viral variants to ensure authorized tests continue to provide accurate results for patients," FDA Commissioner Dr. Stephen Hahn said in the release.

"While these efforts continue, we are working with authorized test developers and reviewing incoming data to ensure that health care providers and clinical staff can quickly and accurately diagnose patients infected with SARS-CoV-2, including those with emerging genetic variants," Hahn said.

Source:
https://www.fda.gov/medical-devices/letters-health-care-providers/genetic-variants-sars-cov-2-may-lead-false-negative-results-molecular-tests-detection-sars-cov-2
Dr. T●●●●z H●●●●●●i and 2 other likes this2 shares
Like
Comment
Share